View Author
screening cancer prostate prostate cancer group study centre round biopsy erspc center value death european control trial result incidence contamination screening group screening round control arm mortality detection control group analysis european randomised study ratio cancer detection rate netherland finland randomised number roobol european randomized study schr öder fh randomized urology level interval table difference italy prostate cancer screening insulator nonattendance rotterdam psa value chromatin men randomised antigen effect core age group cohort interaction reduction psa velocity 1000 men testing sweden randomisation belgium screening arm velocity schroder university volume domain department country subject pca deaths npc domains prostate volume erasmus university biopsied fi rst psa level prostate cancer incidence randomization
6 Most Recent Publications
|
Quality-of-life effects of prostate-specific antigen screening
(Article)
Heijnsdijk, E.A.M. Wever, E.M. Zappa, M. Tammela, T.L. Mäkinen, T. Carlsson, S. Korfage, I.J. Essink-Bot, M.L.E. Otto, S.J. Draisma, G. Bangma, C.H. Roobol, M.J. Auvinen, A. Schröder, F.H. Koning, H.J. de Hugosson, J. Ciatto, S. Nelen, V. Kwiatkowski, M. Villers, A. Páez, A. Moss, S.M. |
2012-08-16
|
|
Towards an optimal interval for prostate cancer screening
(Article)
Leeuwen, P.J. van Roobol, M.J. Kranse, R. Zappa, M. Carlsson, S. Bul, M. Zhu, X.D. Bangma, C.H. Schröder, F.H. Hugosson, J. |
2012-01-01
|
|
PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer
(Article)
Otto, S.J. Moss, S.M. Koning, H.J. de Määttänen, L. Roobol, M.J. Zappa, M. Nelen, V. Kwiatkowski, M. Villers, A. Hugosson, J. Sanchez, A. |
2010-11-01
|
|
Prostate Cancer Mortality Reduction by Prostate-Specific Antigen-Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
(Article)
Roobol, M.J. Kerkhof, M. Lujan, M. Lilja, H. Zappa, M. Denis, L.J. Recker, F. Berenguer, A. Ruutu, M. Kujala, P.M. Bangma, C.H. Aus, G. Schröder, F.H. Tammela, T.L. Villers, A. Rébillard, X. Moss, S.M. Koning, H.J. de Hugosson, J. Auvinen, A. Cuzick, J. Sasieni, P. Hakama, M. Stenman, U.H. Ciatto, S. Nelen, V. Kwiatkowski, M. |
2009-10-01
|
|
Screening and prostate-cancer mortality in a randomized european study
(Article)
Schröder, F.H. Hugosson, J. Denis, L.J. Recker, F. Määpttänen, A.B. Bangma, C.H. Aus, G. Villers, A. Rébillard, X. Kwast, Th.H. van der Blijenberg, B.G. Moss, S.M. Roobol, M.J. Koning, H.J. de Auvinen, A. Tammela, T.L. Ciatto, S. Nelen, V. Kwiatkowski, M. Lujan, M. Lilja, H. Zappa, M. |
2009-03-26
|
|
The value of different screening tests in predicting prostate biopsy outcome in screening for prostate cancer data from a multicenter study (ERSPC)
(Article)
Roobol, M.J. Zappa, M. Määttänen, L. Ciatto, S. |
2007-03-01
|